MedTrace Logo

Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients

NCT00563498 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-07-07

No results posted yet for this study

Summary

The primary purpose of this project is to investigate if addition of glutamine, an amino acid, to standard parenteral nutrition, may improve the clinical outcome of the bone marrrow transplantation reducing the occurrence of veno-occlusive disease and severity of mucositis.

Conditions

  • Pulmonary Veno-Occlusive Disease
  • Hepatic Veno-Occlusive Disease
  • Mucositis

Interventions

DRUG

Glutamine

Sponsors & Collaborators

  • The University of Hong Kong

    collaborator OTHER

  • Fresienius Kabi HK Ltd

    collaborator UNKNOWN

  • Hospital Authority, Hong Kong

    lead OTHER_GOV

Principal Investigators

  • Albert Lie, Dr · Department of Medicine/Division of Haematology, Queen Mary Hospital/ The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2006-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00563498 on ClinicalTrials.gov